CREATE-X
CREATE-X is a Georgia Tech initiative to instill entrepreneurial confidence in students and empower them to launch real startups. The broader goal of this initiative is to provide the knowledge, skills, abilities, and experiences that will give Georgia Tech graduates the confidence to create their own future and confidently pursue entrepreneurial opportunities.
CREATE-X
Industry:
Education Training
Founded:
2014-01-01
Status:
Active
Contact:
404.894.2000
Email Addresses:
[email protected]
Total Funding:
2.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
CanopyBoulder
CanopyBoulder is a mentorship-driven seed-stage business accelerator and investment fund.
CommercialTribe
CT Connect is software to guide and optimize who sales managers coach, where, and perhaps most importantly how.
Platzi
Platzi is an effective online education platform that offers classes on marketing, programming, business, and design.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Marcus Foundation
The Marcus Foundation investment in Grant - CREATE-X
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-23 | Mensari | CREATE-X investment in Pre Seed Round - Mensari | N/A |
| 2022-08-18 | AutoMedTech Inc. | CREATE-X investment in Grant - AutoMedTech Inc. | 5 K USD |
| 2022-07-29 | Tortoise Charging Inc. | CREATE-X investment in Grant - Tortoise Charging Inc. | 5 K USD |
| 2022-07-27 | Quivr | CREATE-X investment in Grant - Quivr | N/A |
| 2022-07-12 | Unifi.ai | CREATE-X investment in Grant - Unifi.ai | 5 K USD |
| 2022-06-30 | GoodAction | CREATE-X investment in Grant - GoodAction | N/A |
| 2022-06-30 | SilverMoxie Ventures | CREATE-X investment in Grant - SilverMoxie Ventures | 5 K USD |
| 2022-05-17 | Haven Now | CREATE-X investment in Pre Seed Round - Haven Now | 5 K USD |
| 2022-03-06 | DevX Labs, Inc. | CREATE-X investment in Pre Seed Round - DevX Labs, Inc. | N/A |
| 2021-08-31 | Intrface Solutions | CREATE-X investment in Grant - Intrface Solutions | N/A |
More informations about "CREATE-X"
CREATE-X - Crunchbase School Profile & Alumni
CREATE-X is a Georgia Tech initiative to instill entrepreneurial confidence in students and empower them to launch real startups. The broader goal of this initiative is to provide the …See details»
Adjuvant Capecitabine for Breast Cancer after Preoperative …
Juvant Therapy (CREATE-X) trial is pro-vided in the Supplementary Appendix, available at NEJM.org. N Engl J Med 2017;376:2147-59. DOI: 10.1056/NEJMoa1612645See details»
CREATE-X and Georgia Tech Startup Exchange Host Founders’ …
On Feb. 23, CREATE-X, in collaboration with GT Startup Exchange, hosted Founders' Forum, at Tech Square ATL Social Club. The event brought three Startup Launch alumni, Tim Felbinger, …See details»
List of top CREATE-X Portfolio Companies - Crunchbase
CREATE-X is a Georgia Tech initiative and accelerator for students to launch successful startups. This list of organizations invested in by CREATE-X provides data on their funding history, …See details»
CREATE-X - Crunchbase
CREATE-X has made 8 diversity investments. Their most recent diversity investment was on Aug 18, 2022, when AutoMedTech raised. $5K. Announced Date . Organization Name . Diversity …See details»
CREATE-X Announces 2025 Jim Pope Fellows | Research
CREATE-X is pleased to announce the next cohort of faculty members selected for the Jim Pope Fellowship for the upcoming academic year. The program provides faculty fellows with funds …See details»
CREATE-X - raizer.app
CREATE-X is a Georgia Tech initiative and accelerator for students to launch successful startups. Learn which startups CREATE-X invests in, number of investmenst, exits, and contact info to …See details»
Verified Organizations on X: What You Need to Know
An organization can add or remove affiliated accounts using the X Verified Organization portal, and any network member who accepts an invitation to affiliate receives an immediate …See details»
CREATE-X (JBCRG-04)｜Clinical Trials｜Japan Breast Cancer …
Create-x (jbcrg-04) GLOBAL This trial is a collaborative study with KBCSG (Korea Breast Cancer Study Group) and KCSG (Korea Cancer Study Group). Investigation of a capecitabine as a …See details»
Get your business started with X
This will allow you to create a Professional Profile. To convert your account, select “X for Professionals” from the left-side menu (swipe right to see it on mobile). ... X and its partners …See details»
Results of the CREATE-X trial - ecancer
The CREATE-X trial was designed to see if further systemic chemotherapy with capecitabine would be beneficial for these patients. Dr Toi and colleagues have previously reported data to …See details»
About X Verified Organizations
Equip your business with tools to boost sales, hire top talent, enhance credibility, and access exclusive market insights. Verified Organizations elevates and distinguishes organizations and …See details»
CREATE-X - Crunchbase
CREATE-X has 2 current employee profiles, including Associate Director Rahul Saxena. CREATE-X has 1 board member or advisor, Omar Balkissoon. Contacts. Edit Contacts …See details»
Phase III Trial of Adjuvant Capecitabine After Standard Neo …
The results of our study were therefore apparently different from those of the meta-analysis and, in particular, from those of the the Capecitabine for Residual Cancer as Adjuvant Therapy …See details»
(PDF) Conflict of Interest and the CREATE-X Trial in the New …
In June 2017, the Capecitabine for Residual Cancer as Adjuvant Therapy (CREATE-X) trial was published in the New England Journal of Medicine (NEJM), one of the most prestigious and …See details»
CREATE-X a role for capecitabine in early-stage breast cancer: an ...
CREATE-X used a unique clinical trial design that excluded patients who obtained a pathologic complete response (pCR) and, therefore, had excellent prognosis without additional therapy. 3 …See details»
Abstract P1-12-02: The tolerance of CREATE-X capecitabine dosing …
Abstract. Background: Capecitabine was shown to prolong overall survival in patients with triple-negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy based …See details»
CREATE-X - Crunchbase
Companies like CREATE-X include Alchemist Accelerator, Startupbootcamp, and CareAcademy. Alchemist Accelerator . San Francisco, California, United States 40 Contacts 51-100 …See details»
CREATE-X a role for capecitabine in early-stage breast cancer: an ...
CREATE-X used a unique clinical trial design that excluded patients who obtained a pathologic complete response (pCR) and, therefore, had excellent prognosis without additional therapy. 3 …See details»
Org Chart Creator | Free Organizational Chart Maker - Miro
Create professional Org Charts with Miro’s free pre-made templates — or create one from scratch using Miro’s Org Chart widget and easy diagramming tools. Skip to: 🚀 2024 was a big year at …See details»